Evidence map›Paper›PMID 26120597›Full record

ArticleJournal of nature and science

Melatonin in Children with Autism Spectrum Disorders: How Does the Evidence Fit Together?

Olivia J Veatch, Suzanne E Goldman, Karen W Adkins, Beth A Malow

Open access · greenAbstract read
In one paragraph

Article in Journal of nature and science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Neurodevelopmental Disorders Commonly Presenting with Sleep Disturbances.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  5. Brief Report: A Gene Enrichment Approach Applied to Sleep and Autism.Journal of autism and developmental disorders · 2020
    Article
  6. Review
  7. Review
  8. Review
  9. Chronic Fluoride Exposure and the Risk of Autism Spectrum Disorder.International journal of environmental research and public health · 2019
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Shorter sleep duration is associated with social impairment and comorbidities in ASD.Autism research : official journal of the International Society for Autism Research · 2017
    Article
  18. Review
  19. New Assessments and Treatments in ASD.Current treatment options in neurology · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Olivia J VeatchSleep Disorders Division, Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
Suzanne E GoldmanSouth Sound Pulmonary & Sleep Medicine, Olympia, WA, USA.
Karen W AdkinsSleep Disorders Division, Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
Beth A MalowSleep Disorders Division, Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
Vanderbilt University Medical Center · US

Funding

The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
YOHIMBINE AS A MODEL OF ORTHOSTATIC INTOLERANCEM01RR000095 · NCRR · VANDERBILT UNIVERSITY · PI DRAKE, WONDER P. · 1985 to 2008
$38.3M
THREE-TIERED PREVENTION MODEL TO BETTER SERVE ALL STUDENP30HD015052 · NICHD · VANDERBILT UNIVERSITY · PI DYKENS, ELISABETH MAY · 1985 to 2014
$18.6M
TRAINING PROGRAM/RESPIRATORY NEUROBIOLOGY AND SLEEPT32HL007713 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI PACK, ALLAN I · 1992 to 2022
$11.9M
Research Project: Sensory and Multisensory Contributions to AutismU54HD083211 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DYKENS, ELISABETH MAY · 2015 to 2019
$7.1M
Melatonin for Sleep in Children with Autism: Safety, Tolerability, and DosingR01HD059253 · NICHD · VANDERBILT UNIVERSITY · PI MALOW, BETH A · 2008 to 2009
$873k
Autism Speaks AS1700Autism Speaks AS7395Autism Speaks AS7722NCATS NIH HHS UL1 TR000445NCRR NIH HHS M01 RR000095NHLBI NIH HHS T32 HL007713NICHD NIH HHS P30 HD015052NICHD NIH HHS R01 HD059253NICHD NIH HHS U54 HD083211
6 · The paper itself

Abstract

Autism spectrum disorders (ASD) are prevalent neurodevelopmental conditions, affecting 1 in 68 children in the United States alone. Sleep disturbance, particularly insomnia, is very common in children diagnosed with ASD, with evidence supporting overlapping neurobiological and genetic underpinnings. One of the most well studied mechanisms related to ASD and insomnia is dysregulation of the melatonin pathway, which has been observed in many individuals with ASD compared to typically developing controls. Furthermore, variation in genes whose products regulate endogenous melatonin modify sleep patterns in humans and have also been implicated in some cases of ASD. However, the relationship between comorbid insomnia, melatonin processing, and genes that regulate endogenous melatonin levels in ASD is complex and requires further study to fully elucidate. The aim of this review is to provide an overview of the current findings related to the effects of genetic variation in the melatonergic pathway on risk for expression of sleep disorders in children with ASD. In addition, functional findings related to endogenous levels of melatonin and pharmacokinetic profiles in this patient population are evaluated.

Indexed as

Autismgeneticsinsomniapharmacokinetics

Identifiers

PMID26120597
PMCPMC4478596
OpenAlexW2135559653

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.